Literature DB >> 32923871

Lynch Syndrome and Breast Cancer Risk: Weighing the Data.

Wendy Kohlmann1.   

Abstract

Entities:  

Year:  2020        PMID： 32923871      PMCID： PMC7446332          DOI： 10.1200/PO.19.00376

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  13 in total

1.  NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.

Authors:  Samir Gupta; Dawn Provenzale; Xavier Llor; Amy L Halverson; William Grady; Daniel C Chung; Sigurdis Haraldsdottir; Arnold J Markowitz; Thomas P Slavin; Heather Hampel; Reid M Ness; Jennifer M Weiss; Dennis J Ahnen; Lee-May Chen; Gregory Cooper; Dayna S Early; Francis M Giardiello; Michael J Hall; Stanley R Hamilton; Priyanka Kanth; Jason B Klapman; Audrey J Lazenby; Patrick M Lynch; Robert J Mayer; June Mikkelson; Shajan Peter; Scott E Regenbogen; Mary A Dwyer; Ndiya Ogba
Journal:  J Natl Compr Canc Netw       Date:  2019-09-01       Impact factor: 11.908

2.  Response to Roberts et al. 2018: cohort ascertainment and methods of analysis impact the association between cancer and genetic predisposition - the tale of breast cancer risk and Lynch syndrome genes MSH6/PMS2.

Authors:  Xia Wang; Jennifer P Brzosowicz; Jong Y Park
Journal:  Genet Med       Date:  2019-02-28       Impact factor: 8.822

3.  Are women with pathogenic variants in PMS2 and MSH6 really at high lifetime risk of breast cancer?

Authors:  D G Evans; E R Woodward; F Lalloo; P Møller; J Sampson; J Burn; G Moeslein; G Capella
Journal:  Genet Med       Date:  2018-12-14       Impact factor: 8.822

4.  Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.

Authors:  Aung Ko Win; Mark A Jenkins; James G Dowty; Antonis C Antoniou; Andrew Lee; Graham G Giles; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Dennis J Ahnen; Stephen N Thibodeau; Graham Casey; Steven Gallinger; Loïc Le Marchand; Robert W Haile; John D Potter; Yingye Zheng; Noralane M Lindor; Polly A Newcomb; John L Hopper; Robert J MacInnis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10-31       Impact factor: 4.254

5.  Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types.

Authors:  Christina Therkildsen; Steen Ladelund; Lars Smith-Hansen; Lars Joachim Lindberg; Mef Nilbert
Journal:  Br J Cancer       Date:  2017-10-24       Impact factor: 7.640

6.  Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.

Authors:  Pål Møller; Toni T Seppälä; Inge Bernstein; Elke Holinski-Feder; Paulo Sala; D Gareth Evans; Annika Lindblom; Finlay Macrae; Ignacio Blanco; Rolf H Sijmons; Jacqueline Jeffries; Hans F A Vasen; John Burn; Sigve Nakken; Eivind Hovig; Einar Andreas Rødland; Kukatharmini Tharmaratnam; Wouter H de Vos Tot Nederveen Cappel; James Hill; Juul T Wijnen; Mark A Jenkins; Kate Green; Fiona Lalloo; Lone Sunde; Miriam Mints; Lucio Bertario; Marta Pineda; Matilde Navarro; Monika Morak; Laura Renkonen-Sinisalo; Mev Dominguez Valentin; Ian M Frayling; John-Paul Plazzer; Kirsi Pylvanainen; Maurizio Genuardi; Jukka-Pekka Mecklin; Gabriela Moeslein; Julian R Sampson; Gabriel Capella
Journal:  Gut       Date:  2017-07-28       Impact factor: 23.059

Review 7.  Risk of breast cancer in Lynch syndrome: a systematic review.

Authors:  Aung Ko Win; Noralane M Lindor; Mark A Jenkins
Journal:  Breast Cancer Res       Date:  2013-03-19       Impact factor: 6.466

8.  Cancer Risks for PMS2-Associated Lynch Syndrome.

Authors:  Sanne W Ten Broeke; Heleen M van der Klift; Carli M J Tops; Stefan Aretz; Inge Bernstein; Daniel D Buchanan; Albert de la Chapelle; Gabriel Capella; Mark Clendenning; Christoph Engel; Steven Gallinger; Encarna Gomez Garcia; Jane C Figueiredo; Robert Haile; Heather L Hampel; John L Hopper; Nicoline Hoogerbrugge; Magnus von Knebel Doeberitz; Loic Le Marchand; Tom G W Letteboer; Mark A Jenkins; Annika Lindblom; Noralane M Lindor; Arjen R Mensenkamp; Pål Møller; Polly A Newcomb; Theo A M van Os; Rachel Pearlman; Marta Pineda; Nils Rahner; Egbert J W Redeker; Maran J W Olderode-Berends; Christophe Rosty; Hans K Schackert; Rodney Scott; Leigha Senter; Liesbeth Spruijt; Verena Steinke-Lange; Manon Suerink; Stephen Thibodeau; Yvonne J Vos; Anja Wagner; Ingrid Winship; Frederik J Hes; Hans F A Vasen; Juul T Wijnen; Maartje Nielsen; Aung Ko Win
Journal:  J Clin Oncol       Date:  2018-08-30       Impact factor: 50.717

9.  Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.

Authors:  Mev Dominguez-Valentin; Julian R Sampson; Toni T Seppälä; Sanne W Ten Broeke; John-Paul Plazzer; Sigve Nakken; Christoph Engel; Stefan Aretz; Mark A Jenkins; Lone Sunde; Inge Bernstein; Gabriel Capella; Francesc Balaguer; Huw Thomas; D Gareth Evans; John Burn; Marc Greenblatt; Eivind Hovig; Wouter H de Vos Tot Nederveen Cappel; Rolf H Sijmons; Lucio Bertario; Maria Grazia Tibiletti; Giulia Martina Cavestro; Annika Lindblom; Adriana Della Valle; Francisco Lopez-Köstner; Nathan Gluck; Lior H Katz; Karl Heinimann; Carlos A Vaccaro; Reinhard Büttner; Heike Görgens; Elke Holinski-Feder; Monika Morak; Stefanie Holzapfel; Robert Hüneburg; Magnus von Knebel Doeberitz; Markus Loeffler; Nils Rahner; Hans K Schackert; Verena Steinke-Lange; Wolff Schmiegel; Deepak Vangala; Kirsi Pylvänäinen; Laura Renkonen-Sinisalo; John L Hopper; Aung Ko Win; Robert W Haile; Noralane M Lindor; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; Jane C Figueiredo; Stephen N Thibodeau; Karin Wadt; Christina Therkildsen; Henrik Okkels; Zohreh Ketabi; Leticia Moreira; Ariadna Sánchez; Miquel Serra-Burriel; Marta Pineda; Matilde Navarro; Ignacio Blanco; Kate Green; Fiona Lalloo; Emma J Crosbie; James Hill; Oliver G Denton; Ian M Frayling; Einar Andreas Rødland; Hans Vasen; Miriam Mints; Florencia Neffa; Patricia Esperon; Karin Alvarez; Revital Kariv; Guy Rosner; Tamara Alejandra Pinero; María Laura Gonzalez; Pablo Kalfayan; Douglas Tjandra; Ingrid M Winship; Finlay Macrae; Gabriela Möslein; Jukka-Pekka Mecklin; Maartje Nielsen; Pål Møller
Journal:  Genet Med       Date:  2019-07-24       Impact factor: 8.822

10.  MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer.

Authors:  Maegan E Roberts; Sarah A Jackson; Lisa R Susswein; Nur Zeinomar; Xinran Ma; Megan L Marshall; Amy R Stettner; Becky Milewski; Zhixiong Xu; Benjamin D Solomon; Mary Beth Terry; Kathleen S Hruska; Rachel T Klein; Wendy K Chung
Journal:  Genet Med       Date:  2018-01-18       Impact factor: 8.822
View more
  2 in total

1.  Significance of rare variants in genes involved in the pathogenesis of Lynch syndrome.

Authors:  Raffaella Liccardo; Matilde Lambiase; Antonio Nolano; Marina De Rosa; Paola Izzo; Francesca Duraturo
Journal:  Int J Mol Med       Date:  2022-04-27       Impact factor: 5.314

2.  Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer.

Authors:  Thais Baccili Cury Megid; Mateus C Barros-Filho; Janina Pontes Pisani; Maria Isabel Achatz
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.